Linda Andre on behalf of the Committee for Truth in Psychiatry to the FDA, 2016 ECT device reclassification.

Psychiatrist Daniel P. Fisher to the FDA on the ECT device reclassifications, 2011.

We are attorneys with a public agency concerned with mental health issues in New York State, and in that context write this letter in opposition to the above-docketed proposal to reclassify from Class Ill to Class Il devices used to administer electro-convulsive therapy ("ECT", also commonly referred to as electro-shock or shock treatment).

Depression and Bipolar Support Alliance (DBSA) on ECT device safety reclassification.

Forced insulin coma and electroshock survivor Leonard Roy Frank shares his perspectives with the FDA on ECT device safety reclassification.